David Szekeres | Executive Vice President, Chief Operating Officer |
Barry Quart | Chief Executive Officer and Chairman |
John Poyhonen | President and Chief Commercial Officer |
Josh Schimmer | Evercore |
Serge Belanger | Needham and Company |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q2 2022 Earnings Conference.
As a reminder, this conference is being recorded.
Now I would like to turn the call over to David Szekeres, Executive Vice President, Chief Operating Officer. Please proceed.